Clinical experimentation with apomorphine in Parkinson's disease
Castaigne, P.; Laplane, D.; Dordain, G.
Research Communications in Chemical Pathology and Pharmacology 2(2): 154-158
1971
ISSN/ISBN: 0034-5164 PMID: 4948431 Document Number: 31882
Document emailed within 1 workday
Related Documents
Giménez-Roldán, S.; García- Muñozguren, S. 2002: Use of apomorphine in Parkinson s disease Revista de Neurologia 35(7): 668-6742005: Apomorphine (Apokyn) for advanced Parkinson's Disease Medical Letter on Drugs and Therapeutics 47(1200): 7-8
Montastruc, J.L.; Rascol, O.; Senard, J.M.; Houin, G.; Rascol, A. 1995: Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? Journal of Neural Transmission. Supplementum 45: 157-161
Pollak, P.; Gervason, C.L.; Deffond, D.; Perret, J.E. 1992: Apomorphine and Parkinson's disease. a major therapeutical progress La Revue du Praticien 42(5): 591-593
Albani, C.; Zangger, I.; Fischer, G. 1992: Subcutaneous apomorphine infusion in the treatment of Parkinson disease Schweizerische Rundschau für Medizin Praxis 81(35): 1011-1015
Pollak, P.; Champay, A.S.; Gaio, J.M.; Hommel, M.; Benabid, A.L.; Perret, J. 1990: Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease Revue Neurologique (Paris) 146(2): 116-122
Jansen, E.N.; van Laar, T. 1990: 'New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine Nederlands Tijdschrift Voor Geneeskunde 134(18): 889-891
Merello, M.; Leiguarda, R. 1995: Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine Medicina 55(1): 5-10
Maggio, R.; Barbier, P.; Corsini, G.U. 1995: Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response Journal of Neural Transmission. Supplementum 45: 133-136
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Nobili, R. 2001: Informed consent in clinical experimentation: typology of the errors most frequently found by the committee for experimentation of the Lombardy region Assistenza Infermieristica e Ricerca: Air 20(2): 90-96
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Poewe, W.; Gerstenbrand, F. 1986: Clinical subtypes of Parkinson disease Wiener Medizinische Wochenschrift 136(15-16): 384-387
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Al-Bunyan, M.A. 2000: Parkinson`s disease. Clinical and electrophysiology evaluation Neurosciences 5(1): 46-49
Barbeau, A. 1972: Biochemical and clinical correlations in Parkinson's disease Revue Neurologique (Paris) 127(2): 253-264
Smolentseva, I.G.; Chupina, L.P.; Amosova, N.A.; Krivonos, O.V. 2014: Clinical evaluation of Parkinson's disease progression Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(6 Part 2): 36-40
Goetz, C.G. 1999: Hallucinations in Parkinson's disease: the clinical syndrome Advances in Neurology 80: 419-423
Poewe, W.H. 1994: Clinical aspects of motor fluctuations in Parkinson's disease Neurology 44(7 Suppl 6: S6-S9